Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched Analysis-Reference-Cited by-同舟云学术

Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched Analysis

Published:2019-02 Issue:1 Volume:17 Page:e113-e122
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Narita Shintaro,Nara Taketoshi,Kanda Sohei,Numakura Kazuyuki,Saito Mitsuru,Inoue Takamitsu,Satoh Shigeru,Nanjo Hiroshi,Tsuchiya Norihiko,Mitsuzuka Koji,Koie Takuya,Kawamura Sadafumi,Ohyama Chikara,Tochigi Tatsuo,Arai Yoichi,Habuchi Tomonori

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference31 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. High-risk prostate cancer-classification and therapy;Chang;Nat Rev Clin Oncol,2014

3. Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017;Gillessen;Eur Urol,2018

4. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma;Shelley;Cancer Treat Rev,2009

5. Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer;Prayer-Galetti;BJU Int,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Staging Intensification Strategies Associated with Radical Prostatectomy for High-Risk Prostate Cancer: Efficacy Evaluation and Exploration of Novel Approaches;Cancers;2024-07-05

2. A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy;Journal of Urology;2024-05

3. Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-08

4. Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients;Journal of Robotic Surgery;2023-07-19

5. Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits;Frontiers in Oncology;2023-05-17